The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1411
Drugs for Hypertriglyceridemia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Fibrates, niacin and fish oil are promoted for treatment of hypertriglyceridemia. HMG-CoA reductase inhibitors (statins) can lower elevated serum concentrations of triglycerides, but less so than fibrates, niacins or fish oil. Lifestyle changes such as weight reduction, exercise and decreasing alcohol intake can also lower serum triglyceride levels and should be tried first.1-3

TRIGLYCERIDE LEVELS AND RISK — Mildly (150-200 mg/dL) and moderately (200-500 mg/dL) increased levels of plasma triglycerides are associated with increased cardiovascular risk. This risk may not be due to triglycerides themselves, but rather to the cholesterol component of triglyceride-rich lipoproteins. Whether lowering triglyceride levels decreases the risk of cardiovascular disease is unclear. Triglyceride concentrations >1000 mg/dL are associated with lipemic plasma, eruptive xanthomas, hepatomegaly and ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Hypertriglyceridemia
Article code: 1411a
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian